News

Recent News Releases

Media Materials

If you are a journalist or member of the media looking for Takeda Oncology resources, visit the media materials section of our newsroom

Contact Us

For media inquiries or reporter requests for more information, contact Oncology Communications via TakedaOncologyNews@takeda.com. If you generally would like to contact us, please visit Contact Us.

For other Takeda news releases, please visit the Takeda.com Newsroom

 

Our Viewpoints

sample-gallery-thumb-image
Lessons From Evolution: From Innate Immunity to Novel Cancer Immunotherapies

In recent years, we’ve seen remarkable progress in combatting devastating cancers, with the rise of immunotherapies across a breadth of therapeutic modalities, from antibody-based immunomodulators to cell-based therapies to other emerging technologies. And yet, while there are more than 30 approved immunotherapies on the market today, only about 15-20% of patients respond to available treatments, demonstrating a necessity for more effective and tolerable options.